Pricing Log in Create free account

iSpecimen Inc. (ISPC) vs ENDRA Life Sciences Inc. (NDRA)

iSpecimen Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.5M against $2.0M — 3.7× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −2,449.0%) and the lower return on invested capital (−539.9% vs 0.00%). Across the 15 metrics below, ENDRA Life Sciences Inc. leads on 10 and iSpecimen Inc. on 5.

Valuation

Metric ISPC NDRA Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.39 17.21 4.24
P/B 0.64 0.98 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA 0.08 n/m 23.44
EV/Sales (1.47) 1.88 5.18
Earnings yield (6,581.25%) (127.31%) (1.50%)
Free cash flow yield (973.26%) (127.37%) 0.00%

Profitability

Metric ISPC NDRA Diagnostics & Research median
Gross margin (108.26%) 0.00% 48.32%
Operating margin (2,020.05%) 0.00% (5.68%)
Net margin (2,449.02%) 0.00% (4.10%)
Free cash flow margin (1,866.61%) 0.00% 0.00%
Return on equity (968.44%) (152.04%) 0.00%
Return on assets (170.09%) (110.08%) (6.05%)
Return on invested capital 0.00% (539.89%) 0.00%

Growth

Metric ISPC NDRA Diagnostics & Research median
Revenue growth (TTM) (92.11%) — 8.99%
EPS growth (last fiscal year) 87.03% 84.32% 20.36%
Revenue growth, 5-year CAGR (25.10%) — 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ISPC NDRA Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 0.82 7.10 2.27
Net debt to EBITDA 0.95 0.14 0.68

Dividend

Metric ISPC NDRA Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ISPC NDRA Diagnostics & Research median
Market cap 2.03m 7.51m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack